Pet DNA Testing Market Size, Share, Growth Demand, Analysis, Forecast 2033
Pet DNA Testing Market Trend By Sample Type (Semen, Saliva, Blood, Others), By Animal (Dogs, Cats, Others), By Test (Genetic Diseases, Breed Profile, Health & Wellness), By End-User (Veterinarians, Breeders, Pet Owners), and By Region: Global Data Interpretation, Analysis and Forecast 2024-2033
- Description
- Table of Content
- Methodology
- Key-Players
Description
The global Pet DNA Testing market size generated approximately $360.5 million in revenue in 2023 and is projected to reach $831.33 million by 2033, reflecting a forecasted compound annual growth rate (CAGR) of 8.8%.
Pet DNA Testing Market: Overview
Deoxyribonucleic Acid (DNA) encodes genetic information in the cells of living organisms, including humans and animals. This long chain of nucleotides carries genetic instructions essential for the functioning and development of organisms, influencing characteristics passed from generation to generation through protein synthesis. DNA is pivotal in understanding genetics and biology, playing a crucial role in various scientific and research fields, including forensic science, biotechnology, healthcare, pharmaceuticals, and evolutionary studies. Pet DNA testing, a significant industry, involves analyzing tissue, hair, or blood samples to extract DNA. Techniques such as DNA sequencing, restriction fragment length polymorphism (RFLP), and polymerase chain reaction (PCR) are used for analysis.
Pet DNA Testing Market: Growth Drivers
Increasing Pet Adoption and Care
The global pet DNA testing market is expected to grow due to the rising rate of pet adoption and the increasing care required for pets to live long, healthy lives. More couples and single individuals are choosing to adopt pets over having biological children, treating pets as family members. This trend drives pet owners’ interest in understanding their pets’ genetics. Additionally, ongoing research and advancements in DNA testing technology have improved accuracy, speed, and accessibility, further propelling market growth.
Pet DNA Testing Market: Opportunities
Growing Awareness
The market is poised for significant growth due to increasing awareness of the benefits of pet DNA testing. Various regulatory bodies and organizations are educating the public about the advantages of such tests. Moreover, untapped markets, especially in developing countries, offer substantial expansion potential and are likely to be targeted by industry players in the forecast period.
Pet DNA Testing Market: Challenges
Privacy Concerns
Despite advancements, privacy concerns regarding pet genetic data remain a significant challenge. Pet owners may be uneasy about their pets’ genetic information being shared. Ensuring data security and preventing privacy breaches is crucial. Additionally, intense market competition requires players to innovate and differentiate to stay ahead.
Key Players Insights:
- DNA MY DOG
- Wisdom Panel
- GENSOL DIAGNOSTICS LLC
- Orivet Genetic Pet Care Ltd
- Basepaws Inc.
- Embark Veterinary Inc.
- PetDx
- Neogen Corp
- and FidoCure.
Report Scope:
Report Attributes | Report Description |
---|---|
Report Name | Pet DNA Testing Market Research Report |
Market Size in 2023 | USD 360.5 Million |
Market Size By 2033 | USD 831.33 Million |
CAGR (2024-2033) | 8.8% |
Base Year | 2023 |
Historic Period | 2020 to 2022 |
Forecast Period | 2024 – 2033 |
Market Segments | By Animal, By Test, By End-user, and By Region. |
Comeptitive Landscape | DNA MY DOG, Wisdom Panel, GENSOL DIAGNOSTICS, LLC, Orivet Genetic Pet Care Ltd, Basepaws, Inc., Embark Veterinary, Inc., PetDx, Neogen Corp, and FidoCure. |
Regional Analysis | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Customization Scope | Free report customization Available after purchase. Report segments, country based Customization will be provided. Moreover, additional customization can be done based on the requirements. |
Pet DNA Testing Market: Segmentation Analysis
The global pet DNA testing market is segmented by sample type, animal, end-user, test, and region.
Sample Type:
- Semen
- Saliva
- Blood
- Others
The saliva segment registered the highest growth in 2021 and is expected to continue leading due to its ease of collection, stability at room temperature, and non-invasive collection methods, providing over 99% accurate results when handled correctly.
Animal:
- Dogs
- Cats
- Others
Test:
- Genetic Diseases
- Breed Profile
- Health & Wellness
End-User:
- Veterinarians
- Breeders
- Pet Owners
The pet owners segment saw the highest growth in 2021 and is expected to generate higher revenue as they are the primary caretakers of pets, requiring detailed DNA analysis for medical and non-medical purposes. These reports help them understand breed, health conditions, medical risks, and parentage.
Pet DNA Testing Market: Regional Segments
The region’s growth is being fueled by increased veterinary budgets and expanding research and development facilities.
In terms of market share, the North American region accounted for more than 40% of the pet DNA testing market in 2022. More funding for pet care and a wider network of pet-care non-governmental organizations are the reasons for the expansion. Additionally, pet trends, such as understanding a pet’s breed, traits, and nutrition plan, are contributing to the increased adoption of canines and felines. Among the millennial generation, who are increasingly adopting dogs, this data is also popular. As a developed nation, the United States has seen a significant increase in the adoption of pets following the pandemic.
- North America
- The U.S.
- Canada
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of The Middle East & Africa
- DNA MY DOG
- Wisdom Panel
- GENSOL DIAGNOSTICS LLC
- Orivet Genetic Pet Care Ltd
- Basepaws Inc.
- Embark Veterinary Inc.
- PetDx
- Neogen Corp
- and FidoCure